Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,128 public trials 2,031 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, not recruiting

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)

NCT05406401

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • BC Cancer Victoria-Clinical Trials Unit ( Site 0105) Victoria, British Columbia, Canada
  • William Osler Health System ( Site 0106) Toronto, Ontario, Canada
  • Hopital du Sacre-Coeur de Montreal ( Site 0108) Montreal, Quebec, Canada
  • Hadassah Medical Center ( Site 0401) Jerusalem, Israel
View all 22 locations
View Trial Details
Active, not recruiting

Blinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults.

NCT03541083

Conditions
ALL, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • BE-Antwerpen Edegem-UZA Antwerp, Belgium
  • BE-Antwerpen-ZNASTUIVENBERG Antwerp, Belgium
  • BE-Brugge-AZBRUGGE Bruges, Belgium
  • BE-Gent-UZGENT Ghent, Belgium
View all 18 locations
View Trial Details
Active, not recruiting

Project Baseline Health Study

NCT03154346

Conditions
ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Baseline Study South San Francisco, California, United States
  • Stanford Medicine Stanford, California, United States
  • California Health and Longevity Institute Westlake Village, California, United States
  • Duke University School of Medicine Durham, North Carolina, United States
View Trial Details
Active, not recruiting

Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.

NCT03225417

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • ICO- Hospital Germans Trias i Pujol Badalona, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
  • Hospital de la Santa Creu I Sant Pau Barcelona, Spain
  • Hospital Universitario Vall D´Hebrón Barcelona, Spain
View Trial Details
Active, not recruiting

A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)

NCT04914741

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +10 more
Locations
  • Concord Repatriation General Hospital Camperdown, New South Wales, Australia
  • St Vincent's Public Hospital Sydney Darlinghurst, New South Wales, Australia
  • Calvary Mater Newcastle Newcastle, New South Wales, Australia
  • Prince of Wales Hospital Randwick, New South Wales, Australia
View all 15 locations
View Trial Details

Related conditions